| CTRI Number |
CTRI/2025/08/092388 [Registered on: 05/08/2025] Trial Registered Prospectively |
| Last Modified On: |
04/08/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cohort Study |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Hormonal predictors of IVF outcome. |
|
Scientific Title of Study
|
Association Of IVF/ICSI Outcome With FSH-AMH And FSH- LH Ratio In Poor Ovarian Reserve |
| Trial Acronym |
NI |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Divya Pandey |
| Designation |
Professor |
| Affiliation |
VMMC and Safdarjung Hospital |
| Address |
Department of Obstetics and Gyenecology, VMMC and Safdarjung hospital,Delhi Department of Obstetics and Gyenecology, VMMC and Safdarjung hospital,Delhi South DELHI 110029 India |
| Phone |
8860198440 |
| Fax |
|
| Email |
dr_devya1@yahoo.co.in |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Ritika Kumari |
| Designation |
PG Student |
| Affiliation |
VMMC and Safdarjung hospital,Delhi |
| Address |
Department of Obstetics and Gyenecology, VMMC and Safdarjung hospital,Delhi
South DELHI 110029 India |
| Phone |
08860198440 |
| Fax |
|
| Email |
ritikakumari7216@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Ritika Kumari |
| Designation |
PG Student |
| Affiliation |
VMMC and Safdarjung hospital,Delhi |
| Address |
Department of Obstetics and Gyenecology, VMMC and Safdarjung hospital,Delhi
South DELHI 110029 India |
| Phone |
08860198440 |
| Fax |
|
| Email |
ritikakumari7216@gmail.com |
|
|
Source of Monetary or Material Support
|
| VMMC and Safdarjung Hospital,MG Marg,Delhi-110029 |
|
|
Primary Sponsor
|
| Name |
VMMC and Safdarjung hospitalDelhi |
| Address |
VMMC and Safdarjung Hospital,MG Marg,Delhi-110029 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Divya Pandey |
VMMC and Safdarjung Hospital |
IVF Centre,Department of Obstetrics and Gyenecology, VMMC and Safdarjung hospital,Delhi South West DELHI |
08860198440
dr_devya1@yahoo.co.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committe |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: N97||Female infertility, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
21.00 Year(s) |
| Age To |
42.00 Year(s) |
| Gender |
Female |
| Details |
Women aged 21 to 42 years with infertility undergoing IVF/ICSI with Anti-müllerian hormone
less than 1.2 ng/ml and,or Antral follicle count less than5
|
|
| ExclusionCriteria |
| Details |
1. Donor gamete cycles
2. PCOS
3. Severe male factor infertility
4. Uncontrolled hypothyroidism
5. Uncontrolled hyperprolactinemia
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
Number of oocytes retrieved Fertilization rate
Embryo quality
Cycle cancellation rate
|
BASELINE |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| nil |
nil |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
31/08/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Background The management of patients with poor ovarian response
(POR) to exogenous gonadotropin stimulation is a challenging problem
in in vitro fertilisation (IVF) cycles. The incidence of poor
response to ovarian stimulation is estimated to be 9-24%. By identifying
reliable, accessible hormonal predictors of IVF success in this subgroup, it is
aimed to enhance clinical decision- making and enable more tailored stimulation
protocols. This could ultimately improve pregnancy outcomes and provide better
prognostic counselling for women with low ovarian reserve.
Based on this evidence collected from the available
literature, the current study has been designed with the aim of studying
association of IVF/ICSI outcome
with FSH-AMH and FSH-
LH ratio in poor ovarian reserve. AIM-To study association of IVF/ICSI outcome with FSH-AMH and FSH-LH ratio in poor ovarian reserve.
OBJECTIVE: To determine the association of IVF/ICSI outcome with FSH-AMH
and FSH- LH ratio in poor
ovarian reserve.
Study Design:
Prospective Observational
Cohort Study
Duration: 18 months
Setting: IVF centre,
Department of Obstetrics and Gynaecology & Department of Pathology,
VMMC & Safdarjung Hospital, New Delhi.
Inclusion Criteria
Women aged 21–42 years with infertility undergoing IVF/ICSI
with Anti-müllerian hormone
< 1.2 ng/ml
and or Antral follicle
count <5
Exclusion Criteria
1. Donor gamete cycles
2. PCOS
3. Severe male factor infertility
4. Uncontrolled hypothyroidism
5. Uncontrolled hyperprolactinemia
After screening, enrollment will be done as per the eligibility criteria; informed consent
will be taken. ART in this
study will include IVF(in vitro fertilisation) and ICSI( intracytoplasmic sperm
injection). Workup of the couple will be
done as per the institutional protocol. Baseline
parameters (FSH,LH, AMH) will be noted on day2/3, antral
follicle count(AFC) will be assessd by transvaginal sonography on
D2/D3 FSH-AMH and FSH-LH ratio will be calculated. Data will be collected as
per the proforma. All women will undergo a standardised ovarian stimulation protocol
with tablet letrozole 5mg/day on day 2- 6, along with gonadotropin
(FSH/HMG) 150-225 IU/day from day2/3 onwards. The
trigger for ovulation will be given injection
hCG when the follicle size is more than or equal to 18mm Oocyte
pickup will be done
35-36 hours after the trigger.
This will be followed by IVF/ICSI. Subsequently, embryo grading will be done. Outcome will
be noted in terms of number of oocytes retrieved Fertilization rate embryo quality and cycle cancellation rate
|